Ptc Therapeutics (PTCT) Treasury Shares (2016 - 2025)
Ptc Therapeutics has reported Treasury Shares over the past 13 years, most recently at $140625.0 for Q4 2025.
- Quarterly results put Treasury Shares at $140625.0 for Q4 2025, down 31.82% from a year ago — trailing twelve months through Dec 2025 was $140625.0 (down 31.82% YoY), and the annual figure for FY2025 was $140625.0, down 31.82%.
- Treasury Shares for Q4 2025 was $140625.0 at Ptc Therapeutics, down from $3.8 million in the prior quarter.
- Over the last five years, Treasury Shares for PTCT hit a ceiling of $3.9 million in Q1 2025 and a floor of $140625.0 in Q4 2025.
- Median Treasury Shares over the past 5 years was $2.7 million (2022), compared with a mean of $2.6 million.
- Biggest five-year swings in Treasury Shares: soared 68.27% in 2022 and later plummeted 92.8% in 2024.
- Ptc Therapeutics' Treasury Shares stood at $1.5 million in 2021, then surged by 65.57% to $2.5 million in 2022, then grew by 13.91% to $2.9 million in 2023, then plummeted by 92.8% to $206250.0 in 2024, then plummeted by 31.82% to $140625.0 in 2025.
- The last three reported values for Treasury Shares were $140625.0 (Q4 2025), $3.8 million (Q3 2025), and $3.8 million (Q2 2025) per Business Quant data.